Cargando…
SERT-to-DAT ratios in early Parkinson’s disease do not correlate with the development of dyskinesias
BACKGROUND: Although the treatment of Parkinson’s disease (PD) is very effective, in the course of the disease, 40% to 60% of patients develop dyskinesias. The pathophysiology of dyskinesias is still unclear. Results of preclinical research suggest that uptake and uncontrolled release of dopamine by...
Autores principales: | Suwijn, Sven R, Berendse, Henk W, Verschuur, Constant VM, Winogrodzka, Ania, de Bie, Rob MA, Booij, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3680321/ https://www.ncbi.nlm.nih.gov/pubmed/23738774 http://dx.doi.org/10.1186/2191-219X-3-44 |
Ejemplares similares
-
Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [(123)I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease
por: Suwijn, Sven R., et al.
Publicado: (2019) -
Serotonin Transporter Availability in Early Stage Parkinson's Disease and Multiple System Atrophy
por: Suwijn, S. R., et al.
Publicado: (2014) -
Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An (123)I-FP-CIT SPECT study
por: Joling, Merijn, et al.
Publicado: (2019) -
Comparison of [(18)F]-FDOPA PET and [(123)I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome
por: Wallert, Elon, et al.
Publicado: (2022) -
The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
por: Suwijn, Sven R, et al.
Publicado: (2015)